We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+7.52%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$104B
AUM Growth
+$6.58B
Cap. Flow
-$453M
Cap. Flow %
-0.43%
Top 10 Hldgs %
10.66%
Holding
2,865
New
128
Increased
1,119
Reduced
1,402
Closed
129

Sector Composition

Rank Sector Weight
1 Technology 17.57%
2 Industrials 13.85%
3 Financials 12.11%
4 Consumer Discretionary 11.36%
5 Healthcare 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOFV
2651
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$40K ﹤0.01%
+460
New +$39.8K
INFI
2652
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$40K ﹤0.01%
13,271
+120
+0.9% +$380
DS
2653
DELISTED
Drive Shack Inc.
DS
$40K ﹤0.01%
12,187
+36
+0.3% +$115
MBII
2654
DELISTED
Marrone Bio Innovations, Inc.
MBII
$40K ﹤0.01%
24,032
+1,185
+5% +$1.98K
EMAN
2655
DELISTED
eMagin Corporation
EMAN
$37K ﹤0.01%
10,591
+394
+4% +$1.22K
OTLK icon
2656
Outlook Therapeutics
OTLK
$191M
$36K ﹤0.01%
725
-22
-3% -$1.02K
CTIC
2657
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$34K ﹤0.01%
13,523
+2,366
+21% +$5.67K
BCIC
2658
BCP Investment Corp
BCIC
$92.9M
$32K ﹤0.01%
1,354
+133
+11% +$3.15K
CFMS
2659
DELISTED
Conformis, Inc. Common Stock
CFMS
$32K ﹤0.01%
1,127
-36
-3% -$850
SLRC icon
2660
SLR Investment Corp
SLRC
$715M
$30K ﹤0.01%
1,592
-99,878
-98% -$1.87M
TTOO
2661
DELISTED
T2 Biosystems, Inc
TTOO
$27K ﹤0.01%
5
MARK
2662
DELISTED
Remark Holdings, Inc.
MARK
$26K ﹤0.01%
1,401
-38
-3% -$711
SRGA
2663
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$26K ﹤0.01%
622
+143
+30% +$7.32K
PEI
2664
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$26K ﹤0.01%
691
-50
-7% -$1.63K
XWEL icon
2665
XWELL
XWEL
$8.61M
$25K ﹤0.01%
813
+64
+9% +$1.82K
DMK
2666
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$25K ﹤0.01%
325
+23
+8% +$1.4K
ELOX
2667
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$25K ﹤0.01%
+309
New +$25.8K
CASI
2668
DELISTED
CASI Pharmaceuticals
CASI
$24K ﹤0.01%
1,564
+88
+6% +$1.48K
CNVS icon
2669
Cineverse
CNVS
$65.6M
$24K ﹤0.01%
941
-30
-3% -$828
JAGX icon
2670
Jaguar Health
JAGX
$4.67M
0
TLPH icon
2671
Talphera
TLPH
$74.2M
$24K ﹤0.01%
882
-46
-5% -$1.23K
ATXS
2672
DELISTED
Astria Therapeutics
ATXS
$23K ﹤0.01%
+1,799
New +$23.4K
OSG
2673
DELISTED
Overseas Shipholding Group Inc.
OSG
$23K ﹤0.01%
11,223
-560
-5% -$1.26K
TYME
2674
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$23K ﹤0.01%
17,992
-559
-3% -$806
EVFM
2675
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$23K ﹤0.01%
1,365
+333
+32% +$6.31K

Similar funds

Victory Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Victory Capital Management held 2,865 positions worth $104B, up 6.7% from $97.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Victory Capital Management's Q2 2021 filing shows 128 new, 1,119 increased, 1,402 reduced and 129 closed positions. Its largest new stake was iShares Core S&P Mid-Cap ETF: 6,251,880 shares worth $336M. The largest sale was Darden Restaurants, an estimated $302M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Victory Capital Management's largest Q2 2021 buy was iShares Core S&P Mid-Cap ETF: 6,251,880 shares worth $336M.
  • Victory Capital Management added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $1.28B increase.
  • Victory Capital Management's biggest Q2 2021 reduction was Darden Restaurants, cutting an estimated $302M.
  • Victory Capital Management fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $245M.
  • Victory Capital Management's ten largest holdings make up 11% of its $104B portfolio in Q2 2021.
  • Victory Capital Management opened 128 new positions and closed 129 in Q2 2021.
  • Victory Capital Management's portfolio value rose 6.7% quarter-over-quarter to $104B.

Based on Victory Capital Management's 13F filing for Q2 2021, filed 3 Aug 2021.